Financhill
Back

BioCardia Quote, Financials, Valuation and Earnings

BioCardia Price Quote

$1.97

BioCardia Key Stats

Sell
34
BioCardia (BCDA) is a Sell

Day range:
$1.88 - $2.06
52-week range:
$1.63 - $10.79
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
9.07
P/B ratio:
3.28%

Volume:
51.4K
Avg. volume:
46K
1-year change:
-79.76%
Market cap:
$9M
Revenue:
$477K
EPS:
$-4.22

How Much Does BioCardia Make?

Data Unavailable

Is BioCardia Growing As A Company?

Data Unavailable

BioCardia Stock Price Performance

  • Did BioCardia Stock Go Up Last Month?
    BioCardia share price went down by -1.01% last month
  • Did BCDA's Share Price Rise Over The Last Year?
    BCDA share price fell by -79.76% over the past 1 year

What Is BioCardia 52-Week High & Low?

  • What Is BioCardia’s 52-Week High Share Price?
    BioCardia has traded as high as $10.79 over the past 52 weeks
  • What Is BioCardia’s 52-Week Low Share Price?
    BioCardia has traded as low as $1.63 over the past 52 weeks

BioCardia Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy BioCardia?

Data Unavailable

Is BioCardia Cash Flow Positive?

Data Unavailable

BioCardia Return On Invested Capital

Data Unavailable

BioCardia Earnings Date & Stock Price

  • What Is BioCardia's Stock Price Today?
    A single share of BCDA can be purchased today for 1.97
  • What Is BioCardia’s Stock Symbol?
    BioCardia trades on the nasdaq under the ticker symbol: BCDA
  • When Is BioCardia’s Next Earnings Date?
    The next quarterly earnings date for BioCardia is scheduled on March 27, 2025
  • When Is BCDA's next ex-dividend date?
    BioCardia's next ex-dividend date is December 22, 2024
  • How To Buy BioCardia Stock?
    You can buy BioCardia shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

BioCardia Competitors

  • Who Are BioCardia's Competitors?
    Below is a list of companies who compete with BioCardia or are related in some way:
    • iBio Inc (IBIO)
    • NovaBay Pharmaceuticals Inc (NBY)
    • Oragenics Inc (OGEN)
    • Palatin Technologies Inc (PTN)
    • Theriva Biologics Inc (TOVX)

BioCardia Dividend Yield

Data Unavailable

BioCardia Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 48.74%
Revenue: -93.02% -100%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 0.00
Downside from Last Price: -100%

Major Shareholders

Data Unavailable